Insider filing · DRUG
Cormorant Asset Management, LP sold $9.8M of Bright Minds Biosciences (DRUG)
Executed Apr 28, disclosed Apr 30, 2 days later.
Value, as filed
$9.8M
109,331 sh × $89.50
Executed
Apr 28
the trade date, as filed
Disclosed
Apr 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CL
Cormorant Asset Management, LP
Other
profile →
Cormorant Asset Management, LP (Other) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in DRUG. The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28.
The name
DRUG
DRUG
DRUG · 3 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Cormorant Asset Management, LP in DRUG
DRUGPURCHASE
BRIGHT MINDS BIOSCIENCES INC.
$4.0M184,331 sh × $21.70
Exec Nov 4 2024
Filed Nov 6 2024 · 5:30 PM ET